Compounds > isoxazoles
Page last updated: 2024-08-21

isoxazoles and Mouth Neoplasms

isoxazoles has been researched along with Mouth Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cui, H; Fu, G; Qiu, Y; Ren, A1
Araki, K; Kamide, D; Shiotani, A; Shiozawa, S; Tanaka, S; Tanaka, Y; Tomifuji, M; Yamashita, T1
Fukazawa, T; Hassan, NM; Kurio, N; Naomoto, Y; Okui, T; Sasaki, A; Shimo, T; Takaoka, M1
Fukazawa, T; Honami, T; Ibaragi, S; Mohammad Monsur Hassan, N; Naomoto, Y; Okui, T; Sasaki, A; Shimo, T; Takaoka, M1

Other Studies

4 other study(ies) available for isoxazoles and Mouth Neoplasms

ArticleYear
Leflunomide inhibits proliferation and tumorigenesis of oral squamous cell carcinoma.
    Molecular medicine reports, 2017, Volume: 16, Issue:6

    Topics: Animals; Apoptosis; Carcinogenesis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Humans; Isoxazoles; Leflunomide; Mice; Mouth Neoplasms; Xenograft Model Antitumor Assays

2017
Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer model.
    Cancer science, 2016, Volume: 107, Issue:5

    Topics: Animals; Benzophenones; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Lymphatic Metastasis; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mouth Neoplasms; Neoplasm Invasiveness; Transcription Factor AP-1; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

2016
Antitumor effect of novel HSP90 inhibitor NVP-AUY922 against oral squamous cell carcinoma.
    Anticancer research, 2011, Volume: 31, Issue:4

    Topics: Animals; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Female; Heat-Shock Proteins; Humans; Immunoenzyme Techniques; Isoxazoles; Mandibular Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Receptor, ErbB-2; Resorcinols; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2011
Novel HSP90 inhibitor NVP-AUY922 enhances the anti-tumor effect of temsirolimus against oral squamous cell carcinoma.
    Current cancer drug targets, 2013, Volume: 13, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cells, Cultured; Female; Head and Neck Neoplasms; HSP90 Heat-Shock Proteins; Human Umbilical Vein Endothelial Cells; Humans; Isoxazoles; Mice; Mice, Nude; Molecular Targeted Therapy; Mouth Neoplasms; Neoplasm Proteins; Neovascularization, Pathologic; Protein Kinase Inhibitors; Random Allocation; Resorcinols; Sirolimus; Squamous Cell Carcinoma of Head and Neck; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2013